123 related articles for article (PubMed ID: 20625051)
1. Attenuation of iodine 125 radiation with vitreous substitutes in the treatment of uveal melanoma.
Oliver SC; Leu MY; DeMarco JJ; Chow PE; Lee SP; McCannel TA
Arch Ophthalmol; 2010 Jul; 128(7):888-93. PubMed ID: 20625051
[TBL] [Abstract][Full Text] [Related]
2. Delivered dose changes in COMS plaque-based ocular brachytherapy arising from vitrectomy with silicone oil replacement.
Morrison H; Larocque MP; Menon G; Sloboda RS; Weis E
Brachytherapy; 2019; 18(5):668-674. PubMed ID: 31272841
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the shielding effectiveness of silicone oil vitreous substitutes when used with Palladium-103 and Iodine-125 eye plaques.
Yang YM; Chow PE; McCannel TA; Lamb JM
Med Phys; 2019 Feb; 46(2):1006-1011. PubMed ID: 30554429
[TBL] [Abstract][Full Text] [Related]
4. The effects of intraocular silicone oil placement prior to iodine 125 brachytherapy for uveal melanoma: a clinical case series.
Ahuja Y; Kapoor KG; Thomson RM; Furutani KM; Shultz RW; Stafford SL; Dev S; Abu-Yaghi NE; Reynolds D; Pulido JS
Eye (Lond); 2012 Nov; 26(11):1487-9. PubMed ID: 22935669
[TBL] [Abstract][Full Text] [Related]
5. Iodine 125 brachytherapy with vitrectomy and silicone oil in the treatment of uveal melanoma: 1-to-1 matched case-control series.
McCannel TA; McCannel CA
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):347-52. PubMed ID: 24721588
[TBL] [Abstract][Full Text] [Related]
6. 23-mm iodine-125 plaque for uveal melanoma: benefit of vitrectomy and silicone oil on visual acuity.
McCannel TA; Kamrava M; Demanes J; Lamb J; Bartlett JD; Almanzor R; Chun M; McCannel CA
Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2461-2467. PubMed ID: 27638702
[TBL] [Abstract][Full Text] [Related]
7. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
Puusaari I; Heikkonen J; Kivelä T
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045
[TBL] [Abstract][Full Text] [Related]
8. Gold nanoparticle-based brachytherapy enhancement in choroidal melanoma using a full Monte Carlo model of the human eye.
Asadi S; Vaez-zadeh M; Masoudi SF; Rahmani F; Knaup C; Meigooni AS
J Appl Clin Med Phys; 2015 Sep; 16(5):344–357. PubMed ID: 26699318
[TBL] [Abstract][Full Text] [Related]
9. Intraocular radiation blocking.
Finger PT; Ho TK; Fastenberg DM; Hyman RA; Stroh EM; Packer S; Perry HD
Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1724-30. PubMed ID: 2211021
[TBL] [Abstract][Full Text] [Related]
10. Periocular triamcinolone for prevention of macular edema after iodine 125 plaque radiotherapy of uveal melanoma.
Horgan N; Shields CL; Mashayekhi A; Teixeira LF; Materin MA; O'Regan M; Shields JA
Retina; 2008; 28(7):987-95. PubMed ID: 18698302
[TBL] [Abstract][Full Text] [Related]
11. Glaucoma After Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors.
Kim EA; Salazar D; McCannel CA; Kamrava M; Demanes DJ; Lamb J; Caprioli J; McCannel TA
J Glaucoma; 2020 Jan; 29(1):1-10. PubMed ID: 31688338
[TBL] [Abstract][Full Text] [Related]
12. The influence of silicone oil used in ophthalmology on the proton therapy of uveal melanomas.
Weber A; Cordini D; Stark R; Heufelder J
Phys Med Biol; 2012 Dec; 57(24):8325-41. PubMed ID: 23201749
[TBL] [Abstract][Full Text] [Related]
13. Finger's amniotic membrane buffer technique: protecting the cornea during radiation plaque therapy.
Finger PT
Arch Ophthalmol; 2008 Apr; 126(4):531-4. PubMed ID: 18413524
[TBL] [Abstract][Full Text] [Related]
14. Dosimetry for 125I seed (model 6711) in eye plaques.
Chiu-Tsao ST; Anderson LL; O'Brien K; Stabile L; Liu JC
Med Phys; 1993; 20(2 Pt 1):383-9. PubMed ID: 8497229
[TBL] [Abstract][Full Text] [Related]
15. Ocular complications after iodine brachytherapy for large uveal melanomas.
Puusaari I; Heikkonen J; Kivelä T
Ophthalmology; 2004 Sep; 111(9):1768-77. PubMed ID: 15350335
[TBL] [Abstract][Full Text] [Related]
16. Vitreous hemorrhage after plaque radiotherapy for uveal melanoma.
Bianciotto C; Shields CL; Pirondini C; Mashayekhi A; Furuta M; Shields JA
Retina; 2012 Jun; 32(6):1156-64. PubMed ID: 22366905
[TBL] [Abstract][Full Text] [Related]
17. Monte Carlo dosimetry of the eye plaque design used at the St. Erik Eye Hospital for (125)I brachytherapy.
Karlsson M; Nilsson J; Lundell M; Carlsson Tedgren A
Brachytherapy; 2014; 13(6):651-6. PubMed ID: 24950821
[TBL] [Abstract][Full Text] [Related]
18. Ultrasonic mirror image from ruthenium plaque facilitates calculation of uveal melanoma treatment dose.
Espensen CA; Jensen PK; Fog LS; Appelt AL; Klemp K; Fledelius HC; Specht L; Kiilgaard JF
Br J Ophthalmol; 2017 Sep; 101(9):1206-1210. PubMed ID: 28159770
[TBL] [Abstract][Full Text] [Related]
19. 125I plaque therapy for uveal melanoma. Analysis of the impact of time and dose factors on local control.
Quivey JM; Augsburger J; Snelling L; Brady LW
Cancer; 1996 Jun; 77(11):2356-62. PubMed ID: 8635107
[TBL] [Abstract][Full Text] [Related]
20. Proliferative radiation retinopathy after plaque radiotherapy for uveal melanoma.
Bianciotto C; Shields CL; Pirondini C; Mashayekhi A; Furuta M; Shields JA
Ophthalmology; 2010 May; 117(5):1005-12. PubMed ID: 20079924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]